EDGAR Filing Documents for 0001171843-17-000220

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001171843-17-000220

Filing Date

2017-01-12

Accepted

2017-01-12 17:20:24

Documents

Period of Report

2017-01-12

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 6-K	f6k_011017.htm	6-K	11384
2	EXHIBIT 99.1	exh_991.htm	EX-99.1	424637
3	EXHIBIT 99.2	exh_992.htm	EX-99.2	301847
4	EXHIBIT 99.3	exh_993.htm	EX-99.3	8513
5	EXHIBIT 99.4	exh_994.htm	EX-99.4	8629
6	GRAPHIC	logo.jpg	GRAPHIC	8679
	Complete submission text file	0001171843-17-000220.txt		768094

Mailing Address 225 PROMENADE DU CENTROPOLIS, SUITE 200 LAVAL A8 H7T 3B3

Business Address 225 PROMENADE DU CENTROPOLIS, SUITE 200 LAVAL A8 H7T 3B3 (450) 687-2262

Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)